Literature DB >> 3490884

The influence of purified recombinant human heavy-subunit and light-subunit ferritins on colony formation in vitro by granulocyte-macrophage and erythroid progenitor cells.

H E Broxmeyer, L Lu, D C Bicknell, D E Williams, S Cooper, S Levi, J Salfeld, P Arosio.   

Abstract

Purified recombinant human heavy subunit (rHF, acidic) and recombinant human light subunit (rLF, basic) ferritins were assessed for their effects in vitro on colony formation by normal human granulocyte-macrophage (CFU-GM) and erythroid (BFU-E) progenitor cells. The purity of the samples was confirmed by electrophoresis in both nondenaturing and denaturing conditions and silver staining. Concentrations of 10(-8) to 10(-10) mol/L rHF caused an approximately 40% significant decrease in colony formation. Some significant activity was detected at 10(-11) mol/L, and activity was lost at 10(-12) mol/L. In contrast, rLF had no significant activity at 10(-8) to 10(-16) mol/L. rHF was significantly active against mouse bone marrow CFU-GM to concentrations as low as 10(-8) to 10(-9) mol/L. The inhibitory activity of rHF was inactivated with three different monoclonal antibodies recognizing the heavy subunit of ferritin, but not with two monoclonal antibodies recognizing the light subunit of ferritin. The inhibitory activity of rHF was similar in the absence or presence of serum, monocytes, and T lymphocytes. We and others have shown an association of a glycosylated natural acidic isoferritin (AIF) with inhibitory activity, but since the rHF was expressed in Escherichia coli and did not bind to concanavalin A, glycosylation of AIF is not an absolute prerequisite for this activity. These results demonstrate that rHF has suppressive activity in vitro and substantiate our original observations using purified natural acidic isoferritins.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3490884

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  11 in total

Review 1.  Preclinical and clinical studies with the hematopoietic colony-stimulating factors and related interleukins.

Authors:  H E Broxmeyer; S Vadhan-Raj
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Neutropenia induced in a patient by treatment with ritodrine: in vitro evaluation of myeloid progenitor colony-forming cells.

Authors:  Kiyomi Tsukimori; Seiichi Morokuma; Takazumi Yoshimura; Koichiro Muta; Norio Wake
Journal:  Br J Clin Pharmacol       Date:  2007-06-19       Impact factor: 4.335

Review 3.  Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic disease.

Authors:  M Jongen-Lavrencic; H R Peeters; G Vreugdenhil; A J Swaak
Journal:  Clin Rheumatol       Date:  1995-09       Impact factor: 2.980

4.  Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes.

Authors:  G A Ramm; R S Britton; R O'Neill; B R Bacon
Journal:  J Clin Invest       Date:  1994-07       Impact factor: 14.808

5.  Ferritin stimulation of a monokine inhibitor of lipopolysaccharide-augmented myelopoiesis is ferroxidase dependent.

Authors:  R Kreisberg; H E Broxmeyer; R N Moore
Journal:  Infect Immun       Date:  1994-07       Impact factor: 3.441

6.  Neutralization of inhibitory activity derived from cells of MDS patients and ML-2 cell line by monoclonal antibodies against H and L-subunit-rich ferritins.

Authors:  V Cukrová; R Neuwirtová
Journal:  Blut       Date:  1990-11

Review 7.  Serum ferritin: Past, present and future.

Authors:  Wei Wang; Mary Ann Knovich; Lan G Coffman; Frank M Torti; Suzy V Torti
Journal:  Biochim Biophys Acta       Date:  2010-03-19

8.  Mutated recombinant human heavy-chain ferritins and myelosuppression in vitro and in vivo: a link between ferritin ferroxidase activity and biological function.

Authors:  H E Broxmeyer; S Cooper; S Levi; P Arosio
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-01       Impact factor: 11.205

9.  H-Ferritin Is Preferentially Incorporated by Human Erythroid Cells through Transferrin Receptor 1 in a Threshold-Dependent Manner.

Authors:  Soichiro Sakamoto; Hiroshi Kawabata; Taro Masuda; Tatsuki Uchiyama; Chisaki Mizumoto; Katsuyuki Ohmori; H Phillip Koeffler; Norimitsu Kadowaki; Akifumi Takaori-Kondo
Journal:  PLoS One       Date:  2015-10-06       Impact factor: 3.240

10.  Impaired polymorphonuclear leukocyte function in chronically hemodialyzed patients with iron overload.

Authors:  W Park; D H Jang; S H Kim; C S Han; W S Shin; H Y Kim; D J Kim
Journal:  Korean J Intern Med       Date:  1988-01       Impact factor: 2.884

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.